By Frank Prenesti
Date: Monday 27 Jan 2020
(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.
By Abigail Townsend
Date: Tuesday 05 Nov 2019
(Sharecast News) - Botox maker Allergan, which is being taken over in a $63bn blockbuster deal, has upped its full-year guidance after posting a forecast-beating set of third-quarter numbers.
By Iain Gilbert
Date: Tuesday 25 Jun 2019
(Sharecast News) - Chicago-based biopharmaceutical company Abbvie snapped up Botox-maker Allergan for roughly $63bn on Tuesday, mostly in cash.
| Currency | US Dollars |
| Share Price | $ 220.18 |
| Change Today | $ -9.13 |
| % Change | -3.98 % |
| 52 Week High | $244.38 |
| 52 Week Low | $169.20 |
| Volume | 9,341,301 |
| Shares Issued | 1,765.26m |
| Market Cap | $388,674m |
| Beta | 0.52 |
| RiskGrade | 122 |
| Strong Buy | 7 |
| Buy | 13 |
| Neutral | 10 |
| Sell | 0 |
| Strong Sell | 0 |
| Total | 30 |

| Time | Volume / Share Price |
| 15:59 | 100 @ $220.55 |
| 15:59 | 174 @ $220.51 |
| 15:59 | 247 @ $220.51 |
| 15:59 | 100 @ $220.51 |
| 15:59 | 100 @ $220.51 |
You are here: research